Many men have heard that prostate cancer is usually slow growing. While that’s often true, it’s only part of the story.
Some prostate cancers develop slowly and may never cause serious problems. Others can be more aggressive prostate cancers that grow or spread much faster than expected. Because it’s impossible to know how a prostate cancer will behave without proper testing, regular screening plays a critical role in protecting men’s health.
At Conrad Pearson Clinic, we encourage men to understand the difference between slow-growing and aggressive prostate cancer — and why staying consistent with prostate cancer screenings can make a life-saving difference.
Why Prostate Cancer Is So Common in Men
Prostate cancer is one of the most common cancers affecting men. In fact, about one in eight men will be diagnosed with prostate cancer during their lifetime, making it the second most common cancer in American men and the second leading cause of cancer-related death among men.
The prostate gland sits just below the bladder and surrounds the urethra, the tube that carries urine out of the body. As men age, the prostate can develop both benign and malignant conditions. A very common noncancerous condition is benign prostatic hyperplasia (BPH), or prostate enlargement, which can cause urinary symptoms such as frequent urination or a weak urine stream.
While these statistics may sound concerning, there is encouraging news. Most prostate cancers are diagnosed while still confined to the prostate, and when caught early, treatment success rates are extremely high.
Slow-Growing vs. Aggressive Prostate Cancer
Many prostate cancers grow slowly over time. In some cases, doctors may recommend active surveillance, which means closely monitoring the cancer with regular testing rather than treating it immediately. However, not all prostate cancers behave this way.
Some cancers are more aggressive, meaning they grow faster and may spread outside the prostate to nearby lymph nodes or bones. These cancers often require earlier treatment. The challenge is that early prostate cancer usually causes no noticeable symptoms, which is why routine screening is so important.
Who Is at Higher Risk for Prostate Cancer?
Several factors can increase a man’s risk of developing prostate cancer. The most common risk factors include:
- Age: Prostate cancer becomes more common as men get older, especially after age 50.
- Race: African American men have a higher risk of developing prostate cancer and are also more likely to develop aggressive forms of the disease.
- Family history: Men who have a father or brother with prostate cancer have an increased risk. Certain inherited genetic conditions may also raise prostate cancer risk.
Understanding these factors can help determine when a man should begin regular prostate cancer screening.
Why Regular Prostate Cancer Screening Is Important
Because prostate cancer often develops without symptoms in its early stages, screening is one of the most effective tools for early detection.
Two simple tests are commonly used:
- A PSA (prostate-specific antigen) blood test
- A digital rectal exam (DRE)
Most men should begin discussing prostate cancer screening with their doctor around age 50. Men with higher risk including African American men or those with a family history of prostate cancer may benefit from starting screening around age 40.
Regular screening allows doctors to detect potential concerns early, when treatment options are often simpler and more successful.
What Happens If Your PSA Is Elevated?
An elevated PSA does not automatically mean cancer is present. PSA levels can rise for several reasons, including infection, inflammation, or prostate enlargement.
If PSA levels remain concerning, your urologist may recommend further evaluation. At Conrad Pearson Clinic, patients have access to advanced diagnostic tools such as specialized blood and urine testing, prostate MRI imaging, and targeted biopsy techniques.
These technologies help physicians determine whether prostate cancer is present and whether it is likely to be slow growing or more aggressive.
A National Leader in Advanced Prostate Cancer Care
At Conrad Pearson Clinic, patients have access to advanced prostate cancer evaluation and treatment through the Conrad Pearson Prostate Cancer Center of Excellence. Our team combines innovative diagnostics, personalized treatment plans, and collaborative care to help patients choose the best path forward.
Dr. Paul Eber is a nationally recognized leader in the evaluation, treatment, and management of advanced prostate cancer. He leads the Advanced Prostate Cancer Clinic at Conrad Pearson, which has been providing advanced therapies since 2010 and currently manages hundreds of patients from Tennessee, Mississippi, and Arkansas.
Dr. Eber focuses on cutting-edge treatments for complex prostate cancer while emphasizing quality of life for his patients. In addition to caring for patients, he travels across the country educating physicians and healthcare teams about the latest advances in prostate cancer treatment.
The Bottom Line
While many prostate cancers grow slowly, some forms can develop and spread more quickly. Because early prostate cancer often causes no symptoms, regular screening remains one of the most powerful ways to detect the disease early and improve outcomes.
If you are over age 40 or have risk factors for prostate cancer, speaking with a urology specialist about screening is an important step toward protecting your long-term health. Early detection saves lives — and it starts with a simple conversation with your doctor.
